nach oben

Medical Oncology

Erschienen in:

01.09.2008 | REVIEW

Understanding and management of male breast cancer: a critical review

verfasst von: Kartikeya Pant, Udayan Dutta

Erschienen in: Medical Oncology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer is a rare disease in men representing nearly 1% of the total breast cancer cases worldwide. While treatments developed for women with breast cancer are often applied to treat men with breast cancer, however, lack of awareness of this disease leads to its detection at a later stage in men. This review discusses male breast cancer and draws comparisons with female breast cancer and discusses current treatments available to treat this disease. It is believed that this review shall provide concise and relevant information increasing the awareness of issues revolving around male breast cancer (MBC).

Ravandi-Kashani F, Hayes TG. Male breast cancer: a review of the literature. Eur J Cancer 1998;34:1341–7.PubMedCrossRef

Giordano Sharon H, Buzdar Aman U, Hortobagyi Gabriel N. Breast cancer in men. Ann Intern Med 2002;137:678–87.PubMed

Arnould N, Pouget O, Gharbi M, Brettes JP. Breast cancer in men: are there similarities with breast cancer in women? Gynecol Obstet Fertil 2006;34:413–9.PubMedCrossRef

Giordano Sharon H. A review of the diagnosis and management of male breast cancer. Oncologist 2005;10:471–9.PubMedCrossRef

Iredale R, Brain K, Williams B, France E, Gray J. The experiences of men with breast cancer in the United Kingdom. Eur J Cancer 2006;42:334–41.PubMedCrossRef

Jonasson JG, Agnarsson BA, Thorlacius S, Eyfjord JE, Tulinius H. Male breast cancer in Iceland. Int J Cancer 1996;65:446–9.PubMedCrossRef

Giordano Sharon H, Cohen Deborah S, Buzdar Aman U, Perkins G, Hortobagyi Gabriel N. Breast carcinoma in men: a population-based study. Cancer 2004;101:51–7.PubMedCrossRef

Joshi MG, Lee AKC, Loda M, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 1996;77:490–8.PubMedCrossRef

Stratton MR, Ford D, Neuhasen S, et al. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 1994;7:103–7.PubMedCrossRef

10.

Karhu R, Laurila E, Kallioniemi A, Syrjakoski K. Large genomic BRCA2 rearrangements and male breast cancer. Cancer Detect Prev 2006;30:530–4.PubMedCrossRef

11.

Thompson D, Easton D. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 2001;68:410–9.PubMedCrossRef

12.

Chakrabarti J, Rampaul RS, Guevara C, et al. The pathology of male breast cancer. Int J Cancer Prev 2005;2:213–23.

13.

Gann PH, Geiger AS, Helenowski IB, Vonesh EF, Chatterton RT. Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins. Cancer Epidemiol Biomarkers Prev 2006;15:39–44.PubMedCrossRef

14.

Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003;86:225–30.PubMedCrossRef

15.

Simpson E, Rubin G, Clyne C, et al. Local estrogen biosynthesis in males and females. Endocr Relat Cancer 1999;6:131–7.PubMedCrossRef

16.

Shozu M, Simpson ER. Aromatase expression of human osteoblast-like cells. Mol Cell Endocrinol 1998;139:117–29.PubMedCrossRef

17.

Shozu M, Zhao Y, Simpson ER. Estrogen biosynthesis in THP1 cells is regulated by promoter switching of the aromatase (CYP19) gene. Endocrinology 1997;138:5125–35.PubMedCrossRef

18.

Simpson ER, Zhao Y, Agarwal VR, et al. Aromatase expression in health and disease. Recent Prog Horm Res 1997;52:185–213;discussion 213–4.PubMed

19.

Agarwal VR, Ashanullah CI, Simpson ER, Bulun SE. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. J Clin Endocrinol Metab 1997;82:70–4.PubMedCrossRef

20.

Zhao Y, Agarwal VR, Mendelson CR, Simpson ER. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 1996;137:5739–42.PubMedCrossRef

21.

Tsai-Morris CH, Aquilano DR, Dufau ML. Cellular localization of rat testicular aromatase activity during development. Endocrinology 1985;116:38–46.PubMedCrossRef

22.

Nitta H, Bunick D, Hess RA, et al. Germ cells of the mouse testis express P450 aromatase. Endocrinology 1993;132:1396–401.PubMedCrossRef

23.

Hemsell DL, Grodin JM, Brenner PF, Siiteri PK, MacDonald PC. Plasma precursors of estrogen II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab 1974;38:476–9.PubMed

24.

de Jong PC, van de Ven J, Nortier HW, et al. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole. Cancer Res 1997;57:2109–11.PubMed

25.

Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955–1996. Cancer 1999;85:629–39.PubMedCrossRef

26.

Cutuli B. Strategies in treating male breast cancer. Expert Opin Pharmacother 2007;8:193–202.PubMedCrossRef

27.

Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 1995;31A:1960–4.PubMedCrossRef

28.

Gennari R, Curigliano G, Jereczek-Fossa Barbara A, et al. Male breast cancer: a special therapeutic problem. Anything new? Int J Oncol 2004;24:663–70.PubMed

29.

Ben Dhiab T, Bouzid T, Gamoudi A, et al. Male breast cancer: about 123 cases collected at the Institute Salah-Azaiz of Tunis from 1979 to 1999. Bull Cancer 2005;92:281–5.PubMed

30.

Agrawal A, Ayantunde AA, Rampaul R, Robertson JFR. Male breast cancer: a review of clinical management. Breast Cancer Res Treat 2007;103:11–21.PubMedCrossRef

31.

Ribiero G. Male breast carcinoma: a review of 301 cases from the Christie Hospital and Holt Radium Institute, Manchester. Br J Cancer 1985;51:115–9.

32.

Nahleh ZA. Hormonal therapy for male breast cancer: a different approach for a different disease. Cancer Treat Rev 2006;32:101–5.PubMedCrossRef

33.

Dutta U, Pant K. Aromatase inhibitors: past, present and future in breast cancer therapy. Med Oncol 2007. doi:10.1007/s12032-007-9019-x.

34.

Turner KJ, Morley M, Atanassova N, Swanston ID, Sharpe RM. Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility. J Endocrinol 2000;164:225–38.PubMedCrossRef

35.

Giordano Sharon H, Duan Z, Kuo Y-F, Hortobagyi Gabriel N, Goodwin James S. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 2006;24:2750–6.PubMedCrossRef

36.

Giordano Sharon H, Perkins George H, Broglio K, et al. Adjuvant systemic therapy for male breast carcinoma. Cancer 2005;104:2359–64.PubMedCrossRef

37.

Fentiman Ian S, Fourquet A, Hortobagyi Gabriel N. Male breast cancer. Lancet 2006;367:595–604.PubMedCrossRef

38.

Bagley CS, Wesley MN, Young RC, Lippman ME. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 1987;10:55–60.PubMedCrossRef

39.

Patel HZ II, Buzdar AU, Hortobagyi GN. Role of adjuvant chemotherapy in male breast cancer. Cancer 1989;64:1583–5.PubMedCrossRef

40.

Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005;365:1687–717.CrossRef

41.

Kiss A, Meryn S. Effect of sex and gender on psychosocial aspects of prostate and breast cancer. BMJ 2001;323:1055–8.PubMedCrossRef

42.

Moynihan C. Theories in health care and research: theories of masculinity. BMJ 1998;317:1072–5.PubMed

43.

Lee C, Owens RG. Issues for psychology of men’s health. J Health Psychol 2002;7:209–17.CrossRef

Titel: Understanding and management of male breast cancer: a critical review
verfasst von: Kartikeya Pant
Udayan Dutta
Publikationsdatum: 01.09.2008
Verlag: Humana Press Inc
Erschienen in: Medical Oncology / Ausgabe 3/2008
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-007-9034-y

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Understanding and management of male breast cancer: a critical review

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2008

Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified

Prostate cancer

Primary mediastinal large B-cell lymphoma mimicking liposarcoma

Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters

Functional characterization of the HOXB13 promoter region

The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie